424B4424B4
Jul 27, 2026Final prospectus0001193125-26-316503
All companies
Trade Scribe Therapeutics Inc
SC
Scribe Therapeutics Inc
SCTXPublic
PublicUnited States(NASDAQ-GM)Best valuation $335.45M1 market
Public listing
Listed· NASDAQ-GM· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
$128.7M
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NASDAQ-GMIPO
SCTXPrice
$20.73
24h
+1.77%
Valuation
$335.45M
24h volume
$2.46M
Type
IPO
Trade Scribe Therapeutics IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 13m ago
SEC IPO filings
Final prospectusEDGAR filings resolved from SCTX / CIK 0001853921.
FWPFWP
Jul 24, 2026Free writing prospectus0001193125-26-314757
Jul 23, 2026Effective9999999995-26-002417
Jul 22, 2026Exchange registration0001354457-26-000723
8-A12B8-A12B
Jul 21, 2026Exchange registration0001193125-26-309199
S-1/AS-1/A
Jul 20, 2026Amended0001193125-26-308330
S-1/AS-1/A
Jul 10, 2026Amended0001193125-26-300994
S-1S-1
Jul 2, 2026Filed0001193125-26-294804
DRS/Afilename1.htm
Jun 12, 2026Confidential draft0001193125-26-269670
DRS/Afilename1.htm
Mar 6, 2026Confidential draft0001193125-26-096844
Jan 9, 2026Confidential draft0001193125-26-009106
Scribe Therapeutics Inc IPO — frequently asked questions
- When did Scribe Therapeutics Inc go public?
- Scribe Therapeutics Inc has already gone public and now trades publicly on NASDAQ-GM under the ticker SCTX.
- Can I buy Scribe Therapeutics Inc stock?
- Yes — Scribe Therapeutics Inc is publicly traded on NASDAQ-GM as SCTX. You can follow its live price, valuation and post-IPO performance above.
- What is Scribe Therapeutics Inc's valuation?
- Scribe Therapeutics Inc's most recent valuation tracked here is $335.45M, derived from live market prices.